A New Jersey appeals court on Tuesday threw out a $223.8 million verdict against Johnson & Johnson in a trial over four plaintiffs’ claims that they developed cancer from being exposed to the company’s talc powder products.
The Superior Court of New Jersey, Appellate Division found that a lower court judge should not have allowed some of the scientific expert testimony the plaintiffs presented to jurors in the case.
A lawyer for the plaintiffs did not immediately respond to a request for comment.
The jury in the case had ordered the company to pay $37.2 million in compensatory damages and $750 million in punitive damages, though the amount was automatically reduced to $186.5 million under state law.
J&J’s win comes after the company in July failed for a second time to move tens of thousands of claims over talc into bankruptcy court, where it hoped to resolve them through a proposed $8.9 billion settlement.
(Reporting By Brendan Pierson in New York; editing by Jonathan Oatis, William Maclean)



Future Cyber Catastrophe Events May Be Different, Yet Not Unknown
Electronic Tolling, Better Signage Could Have Prevented Deadly Ohio Toll Plaza Crash
Emerging Risks to Watch: Quantum Computing, Data Center Buildout, and Peptides
Humans Still Matter to Insurance Consumers, Says Big ‘I’ Survey